SLC family transporters

X Liu - Drug transporters in drug disposition, effects and …, 2019 - Springer
Solute carrier (SLC) family transporters utilize an electrochemical potential difference or an
ion gradient generated by primary active transporters for transporting their substrates across …

Metabolic signature of Warburg effect in cancer: An effective and obligatory interplay between nutrient transporters and catabolic/anabolic pathways to promote tumor …

M Mathew, NT Nguyen, YD Bhutia, S Sivaprakasam… - Cancers, 2024 - mdpi.com
Simple Summary Cancer represents unrestricted growth with the removal of conventional
brakes that control growth under normal conditions. This requires novel mechanisms to …

Human transporters, PEPT 1/2, facilitate melatonin transportation into mitochondria of cancer cells: An implication of the therapeutic potential

X Huo, C Wang, Z Yu, Y Peng, S Wang… - Journal of pineal …, 2017 - Wiley Online Library
Melatonin is present in virtually all organisms from bacteria to mammals, and it exhibits a
broad spectrum of biological functions, including synchronization of circadian rhythms and …

Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin

W Tai, R Mo, J Di, V Subramanian, X Gu… - …, 2014 - ACS Publications
A new glucose-responsive formulation for self-regulated insulin delivery was constructed by
packing insulin, glucose-specific enzymes into pH-sensitive polymersome-based …

Drug transport via the intestinal peptide transporter PepT1

M Brandsch - Current opinion in pharmacology, 2013 - Elsevier
Highlights•The concept that PepT1 serves as a drug transporter has been further
substantiated.•Significant progress has been made on drugs such as cefadroxil and …

Regulation profile of the intestinal peptide transporter 1 (PepT1)

CY Wang, S Liu, XN **e, ZR Tan - Drug design, development and …, 2017 - Taylor & Francis
The intestinal peptide transporter 1 (PepT1) was first identified in 1994. It plays a crucial role
in the absorption of small peptides including not only> 400 different dipeptides and 8,000 …

The role of solute carrier transporters in efficient anticancer drug delivery and therapy

E Puris, G Fricker, M Gynther - Pharmaceutics, 2023 - mdpi.com
Transporter-mediated drug resistance is a major obstacle in anticancer drug delivery and a
key reason for cancer drug therapy failure. Membrane solute carrier (SLC) transporters play …

Synthesis of CDDO–amino acid–nitric oxide donor trihybrids as potential antitumor agents against both drug-sensitive and drug-resistant colon cancer

Y Ai, F Kang, Z Huang, X Xue, Y Lai… - Journal of Medicinal …, 2015 - ACS Publications
Seventeen CDDO–amino acid–NO donor trihybrids (4a–q) were designed and synthesized.
Biological evaluation indicated that the most active compound 4c produced high levels of …

Evaluating human intestinal cell lines for studying dietary protein absorption

PGM Jochems, J Garssen, AM Van Keulen… - Nutrients, 2018 - mdpi.com
With the global population rising, the need for sustainable and resource-efficiently produced
proteins with nutritional and health promoting qualities has become urgent. Proteins are …

Oligopeptide/histidine transporter PHT1 and PHT2—function, regulation, and pathophysiological implications specifically in immunoregulation

M Dong, P Li, J Luo, B Chen, H Jiang - Pharmaceutical Research, 2023 - Springer
The oligopeptide/histidine transporters PHT1 and PHT2, two mammalian solute carrier
family 15A proteins, mediate the transmembrane transport of histidine and some …